Lignocaine 50 mg 5 mL ampoules

Official notice

13 Aug 2017

Last checked

13 Aug 2017

Risk not stated by sourceACCC

An official ACCC notice concerns Lignocaine 50 mg 5 mL ampoules. Heparin is used as a "blood-thinner" in people susceptible to blood-clotting and lignocaine is an anaesthetic. If a patient has an affected pack, there is a risk that they will not have adequate supply of their medicine and could take the incorrect medicine, which could have serious health consequences. Published 2017-08-13.

What to do now

If you or someone you provide care for uses Lignocaine 50 mg/5 mL ampoules (Batch A313, expiry date Nov 2017), please carry out a visual inspection of the contents. In the event that any anomalies are found, return the product to your pharmacy for refund or replacement. Product that has not been found to show any anomalies may be used as normal. Please note that all ampoules supplied in a pack should be identical in all respects and any product details should match those on the external packaging. If you notice any discrepancies with your medicine, return the product to your pharmacist. If you have any other questions or concerns about this issue, talk to your health professional.

Recall number

5f9611aa-6598-41a5-96ac-21658b2a33f0

Official notice

2017-08-13

The hazard

Heparin is used as a "blood-thinner" in people susceptible to blood-clotting and lignocaine is an anaesthetic. If a patient has an affected pack, there is a risk that they will not have adequate supply of their medicine and could take the incorrect medicine, which could have serious health consequences.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

Batch, A313, A473, expiry

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

One batch: Batch A313 Expiry date: Nov 2017 ARTG Number AUST R 49296

Risk / hazard

Heparin is used as a "blood-thinner" in people susceptible to blood-clotting and lignocaine is an anaesthetic. If a patient has an affected pack, there is a risk that they will not have adequate supply of their medicine and could take the incorrect medicine, which could have serious health consequences.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

AU · Australia

Affected area 1

AU · Australia

Source & status

Source

Tier

beta

Category

HOME

Classification

Pharmacy and medical products

App estimate

unspecified

Recall details

Recall number

5f9611aa-6598-41a5-96ac-21658b2a33f0

Classification

Pharmacy and medical products

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 13 Aug 2017. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.